In contrast to the majority of human melanocytic neoplasms, where activation of ERK is linked to the presence of somatic activating mutations in either RAS, BRAF, GNAQ/GNA11 or KIT, these mutations were not found in our GHM samples. The gene discussed is BRAF; the disease is melanocytic neoplasm.